Cleveland-based Chart Industries Inc. will close its medical oxygen plant in Plainfield and merge production with existing
operations in Georgia, resulting in the loss of 130 local jobs.
The company announced the closing on Monday and said it will take about a year to complete it.
Chart acquired the Plainfield manufacturing and customer service operations in November, as part of its purchase of Dublin, Ireland-based Covidien PLC’s liquid-oxygen therapy business.
“We have concluded that the consolidation of the manufacturing and customer service operations into our Canton, Georgia, campus is the most cost-effective solution to meet our customers’ needs,” said Steve Shaw, president of Chart’s biomedical group, in a written release.
The publicly traded Chart disclosed in company filings that the plant closing, severance pay for employees and the year remaining on the building’s lease will cost the company about $7 million.
Chart said it will provide assistance to help employees find new jobs.
The plant in Plainfield operates under Chart’s Caire Inc. division. Caire is the country’s largest provider of respiratory care products for the home health care market.
Its well-known Helios brand of medical and portable personal oxygen supplies is manufactured at the Plainfield facility.